Literature DB >> 16935858

Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain.

Xiaodong Xi1, Panagiotis Flevaris, Aleksandra Stojanovic, Athar Chishti, David R Phillips, Stephen C T Lam, Xiaoping Du.   

Abstract

Outside-in signaling of beta(3) integrins induces and requires phosphorylation at tyrosine 747 (Tyr(747)) and tyrosine 759 (Tyr(759)) of the beta(3) subunit, but the mechanism for this requirement is unclear. On the other hand, a key consequence of integrin signaling, cell spreading, is inhibited by calpain cleavage of beta(3) cytoplasmic domain. Here we show that beta(3) tyrosine phosphorylation inhibits calpain cleavage. Mutating both tyrosines to phenylalanine sensitizes beta(3) to calpain cleavage. Furthermore, phosphorylation at Tyr(747) and Tyr(759) of beta(3) in the focal adhesion sites and the leading edge of spreading platelets was differentially regulated. Selective dephosphorylation of Tyr(759) is associated with calpain cleavage at Tyr(759). Thus, one mechanism by which tyrosine phosphorylation promotes integrin signaling and cell spreading is its inhibition of calpain cleavage of the beta(3) cytoplasmic domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935858     DOI: 10.1074/jbc.C600039200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Signaling during platelet adhesion and activation.

Authors:  Zhenyu Li; M Keegan Delaney; Kelly A O'Brien; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Membrane depolarization inhibits spiral ganglion neurite growth via activation of multiple types of voltage sensitive calcium channels and calpain.

Authors:  Pamela C Roehm; Ningyong Xu; Erika A Woodson; Steven H Green; Marlan R Hansen
Journal:  Mol Cell Neurosci       Date:  2007-11-01       Impact factor: 4.314

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

4.  Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.

Authors:  Nicholas J Anthis; Jacob R Haling; Camilla L Oxley; Massimiliano Memo; Kate L Wegener; Chinten J Lim; Mark H Ginsberg; Iain D Campbell
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

Review 5.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

Review 6.  Targeting integrin and integrin signaling in treating thrombosis.

Authors:  Brian Estevez; Bo Shen; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-25       Impact factor: 8.311

7.  Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model.

Authors:  Jiansong Huang; Yulan Zhou; Xiaoyu Su; Yuanjing Lyu; Lanlan Tao; Xiaofeng Shi; Ping Liu; Zhangbiao Long; Zheng Ruan; Bing Xiao; Wenda Xi; Quansheng Zhou; Jianhua Mao; Xiaodong Xi
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

Review 8.  Regulation of integrin activity and signalling.

Authors:  Carl G Gahmberg; Susanna C Fagerholm; Susanna M Nurmi; Triantafyllos Chavakis; Silvia Marchesan; Mikaela Grönholm
Journal:  Biochim Biophys Acta       Date:  2009-03-14

9.  Insulin, insulin resistance, and platelet signaling in diabetes.

Authors:  Voahanginirina Randriamboavonjy; Ingrid Fleming
Journal:  Diabetes Care       Date:  2009-04       Impact factor: 19.112

10.  Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly.

Authors:  Masami Yamada; Yuko Yoshida; Daisuke Mori; Takako Takitoh; Mineko Kengaku; Hiroki Umeshima; Keizo Takao; Tsuyoshi Miyakawa; Makoto Sato; Hiroyuki Sorimachi; Anthony Wynshaw-Boris; Shinji Hirotsune
Journal:  Nat Med       Date:  2009-09-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.